Sterling Pharma Solutions
Mike Gibson has extensive work experience in the pharmaceutical industry. Mike spent the most recent 11 years at Sterling Pharma Solutions, where they held various roles including Chief Technical Officer, R&D Director, and Sales & Marketing Director. Prior to that, Mike worked at Shasun Pharma Solutions as a Portfolio Manager for four years. Before Shasun, they worked at Rhodia Pharma Solutions as a Product Manager for four years. Mike'scareer started at ChiRex, where they were a Process Manager for three years. Mike began their professional journey at Astra Zeneca as an R&D Chemist for two years.
Mike Gibson attended the University of Oxford from 1992 to 1996, where they pursued a degree in Chemistry, earning an MChem. Prior to their time at Oxford, Mike attended Newcastle Royal Grammar School, although specific details about the duration or degree pursued are not available.
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities